Press N , Fishman JR , Koenig B.Collective fear, individualized risk: the social and cultural context of genetic testing for breast cancer . Nurs Ethics2000; 7: 237-249 .
2.
Burke W , Daly M , Garber J , et al.Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II: BRCA1 and BRCA2. Cancer Genetics Studies Consortium . JAMA1997; 277: 997-1003 .
3.
Veronesi U , Maisonneuve P , Costa A , et al.Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomized women. Italian Tamoxifen Prevention Study , Lancet1998; 352: 93-97 .
4.
Powles T , Eeles R , Ashley S , et al.Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet1998; 352: 98-101 .
5.
Press N , Burke W.If you care about women’s health, perhaps you should care about the risks of direct marketing of tamoxifen to consumers . Effective Clin Pract2000; 3: 98-103 .
6.
Press N , Yasui Y , Reynolds S , et al.Women’s interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations . Am J Med Genet2000 (in press).
